Get the Stockscreener App
0.00
100.00%
-0.0179
After Hours:
.03
0.03
+
Nls Pharmaceutics Ag stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its lead product candidates include Quilience to treat excessive daytime sleepiness and cataplexy; and Nolazol for the treatment of ADHD. The company also developing NLS-4, a selective dopamine reuptake inhibitor to prevent rare sleep disorders; NLS-3, a repurposed reverse ester of methylphenidate for treatment of ADHD; NLS-8, a melatonin ML1A receptor agonist, improved scopolamine-induced amnesia; NLS-11, a norepinephrine and dopamine reuptake inhibitor and muscarinic M1, M2, M3 receptor antagonist; and NLS-12, a norepinephrine and dopamine reuptake inhibitor and muscarinic M4 receptor antagonist. NLS Pharmaceutics AG was incorporated in 2015 and is based in Zurich, Switzerland.
See More
Previous Close:
$0.0179
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$0.04
Nls Pharmaceutics Ag Stock (NLSPW) Company Profile
Name
Nls Pharmaceutics Ag
Sector
Industry
Phone
41 44 512 21 50
Address
The Circle 6, Zurich
Compare NLSPW with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NLSPW
Nls Pharmaceutics Ag
|
0.00 | 0 | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.48 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.36 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.12 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
901.17 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.00 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Nls Pharmaceutics Ag Stock (NLSPW) Latest News
Is NLS Pharmaceutics AG Equity Warrant stock positioned well for digital economyQuarterly Risk Review & Daily Oversold Bounce Ideas - Newser
Can NLS Pharmaceutics AG Equity Warrant stock double in next 5 yearsJuly 2025 Trade Ideas & Smart Money Movement Alerts - Newser
Comparing NLS Pharmaceutics (NASDAQ:NCEL) & Akebia Therapeutics (NASDAQ:AKBA) - Defense World
Is NLS Pharmaceutics AG stock a top momentum playWeekly Investment Summary & Risk Adjusted Buy/Sell Alerts - Newser
NLS Pharmaceutics : to Present at the LD Micro Virtual Invitational Conference on June 10, 2021 - marketscreener.com
Can NLS Pharmaceutics AG stock hit record highs againExit Point & Risk Controlled Daily Plans - BỘ NỘI VỤ
Is NLS Pharmaceutics AG stock ready for breakout2025 Investor Takeaways & Low Volatility Stock Suggestions - moha.gov.vn
Is NLS Pharmaceutics AG stock a contrarian buyJuly 2025 Decliners & Accurate Entry and Exit Point Alerts - moha.gov.vn
Is NLS Pharmaceutics AG stock trading at a premium valuation2025 Volume Leaders & High Accuracy Investment Signals - BỘ NỘI VỤ
What drives NLS Pharmaceutics AG Equity Warrant stock priceResistance Zone Identification & Small Entry Cost Investments - earlytimes.in
Can NLS Pharmaceutics AG stock attract ESG capital inflowsTrade Ideas & AI Driven Stock Reports - newser.com
Is NLS Pharmaceutics AG stock attractive for passive investors2025 Volume Leaders & Free High Return Stock Watch Alerts - newser.com
Can NLS Pharmaceutics AG Equity Warrant recover in the next quarterEarnings Recap Summary & Daily Entry Point Alerts - newser.com
Will NLS Pharmaceutics AG stock gain from lower inflationWeekly Investment Report & AI Enhanced Trade Execution Alerts - newser.com
Will NLS Pharmaceutics AG continue its uptrendWeekly Stock Analysis & Daily Stock Trend Reports - newser.com
Is NLS Pharmaceutics AG stock supported by innovation pipelineJuly 2025 News Drivers & Safe Entry Trade Signal Reports - newser.com
Published on: 2025-11-19 15:14:00 - newser.com
Is NLS Pharmaceutics AG Equity Warrant stock a bargain at current levelsGDP Growth & Reliable Intraday Trade Plans - newser.com
What institutional flow reveals about NLS Pharmaceutics AG Equity WarrantJuly 2025 Spike Watch & Growth Focused Stock Reports - newser.com
What candlestick patterns are forming on NLS Pharmaceutics AG2025 Pullback Review & Expert Curated Trade Ideas - newser.com
How NLS Pharmaceutics AG stock trades before earningsJuly 2025 Selloffs & Technical Entry and Exit Alerts - newser.com
Heatmap analysis for NLS Pharmaceutics AG Equity Warrant and competitors - newser.com
What to do if you’re stuck in NLS Pharmaceutics AG Equity WarrantStop Loss & Real-Time Volume Surge Alerts - newser.com
Will NLS Pharmaceutics AG stock beat EPS estimatesCPI Data & Stock Market Timing Techniques - newser.com
Is NLS Pharmaceutics AG stock positioned for long term growthJuly 2025 Gainers & Weekly Return Optimization Alerts - newser.com
Real time scanner hits for NLS Pharmaceutics AG Equity Warrant explainedJuly 2025 Review & Weekly Stock Performance Updates - newser.com
Will NLS Pharmaceutics AG Equity Warrant stock go up soonQuarterly Performance Summary & Risk Adjusted Swing Trade Ideas - newser.com
Is NLS Pharmaceutics AG Equity Warrant stock attractive for ETFsTrade Volume Summary & Accurate Trade Setup Notifications - newser.com
What the charts say about NLS Pharmaceutics AG todayWatch List & Entry Point Confirmation Signals - newser.com
Nls Pharmaceutics Ag Stock (NLSPW) Financials Data
There is no financial data for Nls Pharmaceutics Ag (NLSPW). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.44%
0.91%
Cap:
|
Volume (24h):